REPLY
11.5.2017 14:02:12 CEST | Business Wire | Press release
Following similar agreements with the Swedish, Danish and Irish National Medicine Verification Organisations, Solidsoft Reply, the Reply group company specialising in enterprise strength solutions on the Microsoft Azure cloud platform, has signed an agreement to implement and operate the National Medicines Verification System in Slovenia; ZAPAZ. ZAPAZ: Zavod za preverjanje avtentičnosti zdravil, meaning “Medicines Verification Institute” is a newly incorporated, not-for-profit organisation responsible for the implementation of the EU’s Falsified Medicines Directive (Directive 2011/62/EU), which mandates safety features on medicines in Europe which will provide Slovenian patients with reassurance against falsified medicines.
Slovenia joins Sweden, Denmark and Ireland in a rapidly increasing list of European markets to engage Solidsoft Reply to implement their certified national blueprint solution.
Mitja Pirman, the Managing Director of ZAPAZ commented that he and his board were looking for a modern future proofed solution, clearly demonstrated with Solidsoft Reply Blueprint System. Solidsoft’s knowledge of the entire National Medicines Verification System and their pragmatism were the key attributes that we were looking for when selecting a long term operational partner.
The implementation of Slovenia’s National Medicines Verification System is a key measure to ensure patient safety by preventing falsified medicines from entering the legitimate medicines supply chain. The Falsified Medicines Directive published by the European Parliament and the European Commission states that each eligible medicinal product must have a unique identifier and tamper-evident seal to allow for the authentication of each medicine pack at the point of dispensing. A European Delegated Act was then passed in February 2016 which requires the full implementation of the European Medicines Verification System by February 2019.
Solidsoft Reply was previously selected by the European Medicines Verification Organisation (EMVO) to implement the European Medicines Verification Hub, enabling medicine manufacturers and parallel distributors to upload their pack data which is then routed to appropriate national systems. The Solidsoft Reply National Blueprint solution, has been designed from the ground up to meet the exact needs of the FMD. It is implemented using the very latest Microsoft technology and platformed on the Microsoft Azure Cloud. The futureproofed solution automatically scales ensuring that the challenging response times are always able to be achieved.
The European Medicines Verification Organisation (EMVO) represent the key stakeholders in the European pharmaceutical supply chain, EFPIA, Medicines for Europe, EAEPC, GIRP and PGEU.
ZAPAZ has been established through a collaboration between key stakeholders in the pharmaceutical industry. Its founder members include:
- Forum of international research and development pharmaceutical companies, EIG
- Association of Slovenian medicinal product manufacturers
- Slovenian chamber of pharmacy
- Slovenian chamber of commerce, Section of medicinal product wholesalers
Solidsoft Reply
Solidsoft Reply is the Reply group company
creating enterprise strength solutions on-premises and utilising the
Microsoft Azure cloud platform. A global award winning Microsoft Gold
certified partner, Solidsoft Reply specialises in: System Integration on
the Microsoft platform, including BizTalk Server and Logic-Apps,
Service-Bus and API-Management on Microsoft’s Azure PaaS public cloud;
Custom Application Development on the Microsoft Azure platform; Business
critical application support; Azure operational services and Application
Lifecycle Management. A published thought leader and trusted advisor to
Microsoft, engineering innovative solutions since 1993, Solidsoft Reply
has helped over 500 enterprise clients succeed. www.solidsoftreply.com
Reply
Reply specialises in the design and implementation of
solutions based on new communication channels and digital media. Through
its network of specialist companies, Reply supports some of Europe’s
leading industrial groups in Telco & Media, Industry & Services, Banks &
Insurance, and Public Administration to define and develop business
models, suited to the new paradigms of Big Data, Cloud Computing,
Digital Media and the Internet of Things. Reply services include:
Consulting, System Integration and Digital Services.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170511005563/en/
Contact:
Reply
Media Contacts
Fabio Zappelli
f.zappelli@reply.com
or
Roberta
Giani
r.giani@reply.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FlightSafety International Receives FAA Approval for Virtual Aircraft Preflight Inspection with Evaluation Mode6.5.2026 16:05:00 CEST | Press release
Three aircraft programs approved, with three more expected to receive approval in 2026 FlightSafety International Inc., the global leader in aviation training and simulation technology, today announced it has received Federal Aviation Administration (FAA) approval for Virtual Aircraft Preflight Inspection (VAPI) with Evaluation Mode for three aircraft training programs: the Embraer EMB-550, Gulfstream G500/G600, and Citation Latitude. This innovative capability allows pilots in initial training to complete a 3D virtual aircraft preflight inspection while in Training Mode, with the added ability to transition directly into the flight deck, followed by Evaluation Mode, that allows pilots to do their preflight check ride portion. “VAPI represents a meaningful advancement in training innovation,” said David Penney, VP of Safety, Courseware and Regulatory Affairs, FlightSafety International. “By leveraging an immersive 3D environment, it offers pilots a more engaging and practical way to de
Riskified Unveils Next-Generation AI Suite at Ascend 2026, Empowering Merchants with Unprecedented Visibility and Control Over Ecommerce Risk6.5.2026 15:00:00 CEST | Press release
New capabilities include Riskified ARIA the AI Risk Analyst, Identity Explore 2.0, and an enhanced Decision Studio, giving merchants the power to see, understand, and act on network risk intelligence like never before Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today announced a major leap forward in its AI platform capabilities, introducing a powerful suite of control and empowerment tools designed to give merchant fraud teams complete visibility into risk patterns and identity behavior, conversational AI-driven insights, and the ability to surgically tailor their risk strategies. The innovation suite was announced onstage at Ascend 2026, Riskified’s premier global summit series, taking place May 4-6, 2026, at the Conrad New York Downtown in Manhattan, NY. With global ecommerce continuing to expand and losses from AI-driven fraud attacks projected to spike, particularly with the rise of agentic commerce, where AI bots may conduct transactions on b
Twilio’s Next Generation Platform: An Infrastructure Layer for Every Conversation in the Agentic Era6.5.2026 15:00:00 CEST | Press release
New platform capabilities orchestrate context-rich conversations with persistent memory across multiple channels for humans and AI agentsConversation Memory, Conversation Orchestrator, Conversation Intelligence, and Agent Connect provide the nervous system for modern customer engagement Twilio (NYSE: TWLO), the infrastructure for customer engagement in the AI era, kicked off its user conference, SIGNAL, by unveiling its next generation platform capabilities for the agentic era. Generally available today, Conversation Memory, Conversation Orchestrator, Conversation Intelligence, and Agent Connect combine to turn disparate interactions into continuous, intelligent, and personal conversations across humans, agents, and systems. “The agentic era is here. Agents are joining conversations alongside the people they represent, and modern customer engagement requires an infrastructure that serves both equally,” said Khozema Shipchandler, Chief Executive Officer at Twilio. “Twilio’s new platform
Vultr, SUSE & Supermicro Debut Unified Cloud-to-Edge Architecture for Global AI Scaling6.5.2026 14:00:00 CEST | Press release
The strategic partnership bridges the gap between regional cloud and the far edge, combining ruggedized hardware and GitOps-driven Kubernetes to streamline large-scale AI deployments Vultr, the world's largest privately-held cloud infrastructure company, in collaboration with SUSE and Supermicro, today announces a strategic architectural framework designed to solve the complexities of deploying and operating AI workloads across distributed environments. As AI moves closer to the point of data creation - from manufacturing floors to retail storefronts - organizations face significant challenges in latency, cost and operational consistency. This joint initiative provides a seamless, Cloud-to-Edge pipeline that integrates high-performance hardware, localized cloud infrastructure, and unified Kubernetes management. The partnership addresses the reality that sending all data back to a central cloud is no longer viable for real-time AI. The solution breaks down the infrastructure into three
Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program6.5.2026 14:00:00 CEST | Press release
Waiv, formerly Owkin Dx, to leverage its digital pathology platform encompassing foundation models and AI methodology for ADC biomarker discovery program Waiv, formerly Owkin Dx, a Paris-based company catalyzing AI precision testing, today announced it has entered a collaboration with Daiichi Sankyo (TSE: 4568) to lead digital pathology biomarker discovery for an antibody-drug conjugate (ADC) program. With deep expertise across diverse pathology and multimodal data, and a global data network spanning academic institutions, hospitals, and laboratories, Waiv has a proven track record delivering AI-powered biomarker solutions across the full drug development lifecycle. Under the collaboration, Waiv will apply its end-to-end computational pathology platform to early phase data. This includes tumor microenvironment (TME) analysis across both hematoxylin and eosin (H&E) and immunohistochemistry (IHC) stained samples, as well as biomarker discovery and outcome prediction capabilities aimed at
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
